Published in Proc Natl Acad Sci U S A on August 01, 2000
Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog (2008) 2.71
Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections. PLoS Pathog (2008) 2.09
Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants. Proc Natl Acad Sci U S A (2002) 2.04
Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A (2004) 2.00
Cathelin-related antimicrobial peptide differentially regulates T- and B-cell function. Eur J Immunol (2011) 1.67
Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia. Proc Natl Acad Sci U S A (2004) 1.66
The Bacillus subtilis extracytoplasmic-function sigmaX factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J Bacteriol (2004) 1.63
Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation. Antimicrob Agents Chemother (2006) 1.58
Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother (2001) 1.56
Innate immune response of oral and foreskin keratinocytes: utilization of different signaling pathways by various bacterial species. Infect Immun (2004) 1.55
Identification of Legionella pneumophila rcp, a pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes intracellular infection. Infect Immun (2001) 1.50
LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob Agents Chemother (2006) 1.45
Antimicrobial peptides. Pharmaceuticals (Basel) (2013) 1.37
Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob Agents Chemother (2001) 1.36
Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications. Antimicrob Agents Chemother (2005) 1.27
Effects of the antimicrobial peptide temporin L on cell morphology, membrane permeability and viability of Escherichia coli. Biochem J (2004) 1.22
Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures. Antimicrob Agents Chemother (2002) 1.17
mig-14 is a Salmonella gene that plays a role in bacterial resistance to antimicrobial peptides. J Bacteriol (2002) 1.16
Cationic amphiphiles, a new generation of antimicrobials inspired by the natural antimicrobial peptide scaffold. Antimicrob Agents Chemother (2010) 1.15
Microbicidal properties and cytocidal selectivity of rhesus macaque theta defensins. Antimicrob Agents Chemother (2007) 1.13
Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother (2002) 1.10
A family of helminth molecules that modulate innate cell responses via molecular mimicry of host antimicrobial peptides. PLoS Pathog (2011) 1.10
Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol (2002) 1.10
Host defense peptides in wound healing. Mol Med (2008) 1.10
Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance? Int J Mol Sci (2009) 1.08
Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages. Cell Microbiol (2005) 1.08
P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients. Antimicrob Agents Chemother (2001) 1.08
Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob Agents Chemother (2010) 1.08
Antimicrobial peptides from marine invertebrates. Antimicrob Agents Chemother (2004) 1.08
Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect Immun (2010) 1.08
Membrane binding, structure, and localization of cecropin-mellitin hybrid peptides: a site-directed spin-labeling study. Biophys J (2004) 1.06
Paratransgenic control of vector borne diseases. Int J Biol Sci (2011) 1.06
rBPI(21) promotes lipopolysaccharide aggregation and exerts its antimicrobial effects by (hemi)fusion of PG-containing membranes. PLoS One (2009) 1.06
Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo. Protein Sci (2008) 1.05
D-alanylation of lipoteichoic acids confers resistance to cationic peptides in group B streptococcus by increasing the cell wall density. PLoS Pathog (2012) 1.05
Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. Appl Environ Microbiol (2006) 1.04
In vitro activity and potency of an intravenously injected antimicrobial peptide and its DL amino acid analog in mice infected with bacteria. Antimicrob Agents Chemother (2004) 1.04
Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol (2007) 1.04
Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens. Antimicrob Agents Chemother (2013) 1.03
Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf (2004) 1.00
In vitro activity of the histatin derivative P-113 against multidrug-resistant pathogens responsible for pneumonia in immunocompromised patients. Antimicrob Agents Chemother (2005) 1.00
Surface-active fungicidal D-peptide inhibitors of the plasma membrane proton pump that block azole resistance. Antimicrob Agents Chemother (2005) 1.00
The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury. J Transl Med (2011) 0.99
In vitro antimicrobial activity of natural toxins and animal venoms tested against Burkholderia pseudomallei. BMC Infect Dis (2006) 0.99
Quinolones sensitize gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother (2006) 0.97
Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet Pathol (2006) 0.97
Characterization of UDP-glucose dehydrogenase and UDP-glucose pyrophosphorylase mutants of Proteus mirabilis: defectiveness in polymyxin B resistance, swarming, and virulence. Antimicrob Agents Chemother (2010) 0.97
Klebsiella pneumoniae OmpA confers resistance to antimicrobial peptides. Antimicrob Agents Chemother (2008) 0.96
Conventional and unconventional antimicrobials from fish, marine invertebrates and micro-algae. Mar Drugs (2010) 0.96
Potential therapeutic role of cationic peptides in three experimental models of septic shock. Antimicrob Agents Chemother (2002) 0.94
Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother (2006) 0.94
Designed beta-boomerang antiendotoxic and antimicrobial peptides: structures and activities in lipopolysaccharide. J Biol Chem (2009) 0.94
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. Antimicrob Agents Chemother (2007) 0.94
The human antimicrobial peptide LL-37, but not the mouse ortholog, mCRAMP, can stimulate signaling by poly(I:C) through a FPRL1-dependent pathway. J Biol Chem (2013) 0.94
Current developments in the therapy of protozoan infections. Open Med Chem J (2011) 0.93
Imcroporin, a new cationic antimicrobial peptide from the venom of the scorpion Isometrus maculates. Antimicrob Agents Chemother (2009) 0.93
Chicken cathelicidin-B1, an antimicrobial guardian at the mucosal M cell gateway. Proc Natl Acad Sci U S A (2007) 0.93
Role of RppA in the regulation of polymyxin b susceptibility, swarming, and virulence factor expression in Proteus mirabilis. Infect Immun (2008) 0.92
Recognition of pathogenic microbes by the Drosophila phagocytic pattern recognition receptor Eater. J Biol Chem (2011) 0.92
Orientation of a beta-hairpin antimicrobial peptide in lipid bilayers from two-dimensional dipolar chemical-shift correlation NMR. Biophys J (2006) 0.91
Structure and membrane interactions of the antibiotic peptide dermadistinctin K by multidimensional solution and oriented 15N and 31P solid-state NMR spectroscopy. Biophys J (2009) 0.91
Two cathelicidin genes are present in both rainbow trout (Oncorhynchus mykiss) and atlantic salmon (Salmo salar). Antimicrob Agents Chemother (2006) 0.91
Differential utilization of nuclear factor-kappaB signaling pathways for gingival epithelial cell responses to oral commensal and pathogenic bacteria. Oral Microbiol Immunol (2008) 0.91
Interaction of CAP18-derived peptides with membranes made from endotoxins or phospholipids. Biophys J (2001) 0.91
A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J Antibiot (Tokyo) (2013) 0.90
Induction of {beta}-defensin resistance in the oral anaerobe Porphyromonas gingivalis. Antimicrob Agents Chemother (2005) 0.90
A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media. Mol Immunol (2006) 0.89
Constitutive expression of transgenes encoding derivatives of the synthetic antimicrobial peptide BP100: impact on rice host plant fitness. BMC Plant Biol (2012) 0.89
Proteus mirabilis pmrI, an RppA-regulated gene necessary for polymyxin B resistance, biofilm formation, and urothelial cell invasion. Antimicrob Agents Chemother (2010) 0.88
Structures of β-hairpin antimicrobial protegrin peptides in lipopolysaccharide membranes: mechanism of gram selectivity obtained from solid-state nuclear magnetic resonance. Biochemistry (2011) 0.88
Identification of synthetic host defense peptide mimics that exert dual antimicrobial and anti-inflammatory activities. Clin Vaccine Immunol (2012) 0.87
Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2. Antimicrob Agents Chemother (2005) 0.87
NMR structures and interactions of temporin-1Tl and temporin-1Tb with lipopolysaccharide micelles: mechanistic insights into outer membrane permeabilization and synergistic activity. J Biol Chem (2011) 0.87
The Aspergillus giganteus antifungal protein AFPNN5353 activates the cell wall integrity pathway and perturbs calcium homeostasis. BMC Microbiol (2011) 0.87
Energetics and partition of two cecropin-melittin hybrid peptides to model membranes of different composition. Biophys J (2007) 0.86
Treatment and prevention of Staphylococcus epidermidis experimental biomaterial-associated infection by bactericidal peptide 2. Antimicrob Agents Chemother (2006) 0.86
Increased sleep promotes survival during a bacterial infection in Drosophila. Sleep (2014) 0.86
Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11. Antimicrob Agents Chemother (2006) 0.86
A role for antimicrobial peptides in intestinal microsporidiosis. Parasitology (2008) 0.86
Altered fungal sensitivity to a plant antimicrobial peptide through over-expression of yeast cDNAs. Curr Genet (2005) 0.85
The role of lysozyme in the prophenoloxidase activation system of Manduca sexta: an in vitro approach. Dev Comp Immunol (2009) 0.85
Serratia marcescens arn, a PhoP-regulated locus necessary for polymyxin B resistance. Antimicrob Agents Chemother (2014) 0.84
Role of lysozyme inhibitors in the virulence of avian pathogenic Escherichia coli. PLoS One (2012) 0.84
A Toll-Spätzle pathway in the tobacco hornworm, Manduca sexta. Insect Biochem Mol Biol (2012) 0.83
Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob Agents Chemother (2012) 0.83
Rickettsia peacockii, an endosymbiont of Dermacentor andersoni, does not elicit or inhibit humoral immune responses from immunocompetent D. andersoni or Ixodes scapularis cell lines. Dev Comp Immunol (2007) 0.83
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut (2003) 0.83
The post-antibiotic era: promising developments in the therapy of infectious diseases. Int J Biomed Sci (2010) 0.83
D-alanine modification of a protease-susceptible outer membrane component by the Bordetella pertussis dra locus promotes resistance to antimicrobial peptides and polymorphonuclear leukocyte-mediated killing. J Bacteriol (2013) 0.83
Structural dynamic of a self-assembling peptide d-EAK16 made of only D-amino acids. PLoS One (2008) 0.82
The Antimicrobial Defense of the Pacific Oyster, Crassostrea gigas. How Diversity may Compensate for Scarcity in the Regulation of Resident/Pathogenic Microflora. Front Microbiol (2012) 0.82
In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci. Antimicrob Agents Chemother (2007) 0.82
Natriuretic peptides modify Pseudomonas fluorescens cytotoxicity by regulating cyclic nucleotides and modifying LPS structure. BMC Microbiol (2008) 0.82
An experimental heat wave changes immune defense and life history traits in a freshwater snail. Ecol Evol (2013) 0.82
Minimum requirements of hydrophobic and hydrophilic features in cationic peptide antibiotics (CPAs): pharmacophore generation and validation with cationic steroid antibiotics (CSAs). J Mol Model (2008) 0.81
De novo transcriptome sequencing of the Octopus vulgaris hemocytes using Illumina RNA-Seq technology: response to the infection by the gastrointestinal parasite Aggregata octopiana. PLoS One (2014) 0.81
β-Microseminoprotein endows post coital seminal plasma with potent candidacidal activity by a calcium- and pH-dependent mechanism. PLoS Pathog (2012) 0.81
Immune response and anti-microbial peptides expression in Malpighian tubules of Drosophila melanogaster is under developmental regulation. PLoS One (2012) 0.81
Effects of a skin neuropeptide (substance p) on cutaneous microflora. PLoS One (2013) 0.81
Listeria monocytogenes cell wall constituents exert a charge effect on electroporation threshold. Biochim Biophys Acta (2011) 0.81
Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity (1999) 17.40
Peptide antibiotics. Antimicrob Agents Chemother (1999) 5.76
Cationic peptides: a new source of antibiotics. Trends Biotechnol (1998) 5.10
Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry (1999) 3.88
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity. Antimicrob Agents Chemother (1997) 3.12
Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun (1994) 2.92
Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol (1999) 2.85
Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem (1996) 2.78
The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci U S A (1995) 2.36
Gram-positive organisms and sepsis. Arch Intern Med (1994) 2.27
Human beta-defensin-2. Int J Biochem Cell Biol (1999) 2.19
Inducible expression of an antibiotic peptide gene in lipopolysaccharide-challenged tracheal epithelial cells. Proc Natl Acad Sci U S A (1996) 2.18
Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun (1996) 2.13
Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J Exp Med (1998) 2.08
Binding of bacterial peptidoglycan to CD14. J Biol Chem (1998) 1.97
Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect Immun (1988) 1.92
Activation of human monocytes by streptococcal rhamnose glucose polymers is mediated by CD14 antigen, and mannan binding protein inhibits TNF-alpha release. J Immunol (1995) 1.89
Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun (1999) 1.87
Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother (1999) 1.78
In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother (1999) 1.77
Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines. Infect Immun (1995) 1.72
Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob Agents Chemother (1998) 1.50
Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol (1998) 1.49
Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry (1999) 1.48
Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry (1998) 1.45
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun (1997) 1.40
Interaction of cationic peptides with lipoteichoic acid and gram-positive bacteria. Infect Immun (1999) 1.40
Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun (1994) 1.38
Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein. Infect Immun (1998) 1.25
Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against murine endotoxemia. Infect Immun (1998) 1.24
Preliminary experimental anticancer activity of cecropins. Pept Res (1995) 1.20
Liberation of endotoxin from Escherichia coli by addition of antibiotics. Jpn J Exp Med (1980) 1.18
Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol (1998) 1.18
Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model. J Antimicrob Chemother (1998) 1.15
The role of tyrosine kinases and map kinases in LPS-induced signaling. Prog Clin Biol Res (1998) 1.08
PR-39, a syndecan-inducing antimicrobial peptide, binds and affects p130(Cas). J Biol Chem (1998) 1.07
Macrophages--proliferation, activation, and cell cycle proteins. J Leukoc Biol (1999) 1.01
Proinflammatory cytokine production by human peripheral blood mononuclear cells stimulated with cell-free supernatants of Viridans streptococci. Cytokine (1996) 0.92
Neutrophilic defensins penetrate the blood-brain barrier. J Neurosci Res (1995) 0.91
Effect of local application of the antimicrobial peptide IB-367 on the incidence and severity of oral mucositis in hamsters. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1999) 0.87
Improvement in survival with peptidyl membrane interactive molecule D4B treatment after burn wound infection. Arch Surg (1998) 0.83
Impact of point-of-care testing on patients' length of stay in a large emergency department. Clin Chem (1996) 2.59
An IgM lambda antibody to Escherichia coli produces false-positive results in multiple immunometric assays. Clin Chem (2000) 2.28
Clinical utility of biochemical analysis of cerebrospinal fluid. Clin Chem (1995) 2.11
Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J Immunol (2000) 1.93
Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother (1999) 1.78
The benefits of a hospital based community services liaison pharmacist. Pharm World Sci (2000) 1.48
Spontaneous secretion of IgG subclasses by intestinal mononuclear cells: differences between ulcerative colitis, Crohn's disease, and controls. Clin Exp Immunol (1986) 1.46
Use of a treatment protocol in the management of community-acquired lower respiratory tract infection. J Antimicrob Chemother (2000) 1.39
Conjugated, but not unconjugated, bilirubin negatively interferes in Hitachi 747 assay of inorganic phosphorus. Clin Chem (1993) 1.39
Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol (1987) 1.38
Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem (1998) 1.37
Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis (1990) 1.35
An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide. J Clin Invest (1991) 1.24
Interaction of polyphemusin I and structural analogs with bacterial membranes, lipopolysaccharide, and lipid monolayers. Biochemistry (2000) 1.22
Correlation of plasma concentrations of cystatin C and creatinine to inulin clearance in a pediatric population. Clin Chem (1998) 1.15
Management of Helicobacter pylori eradication--the influence of structured counselling and follow-up. Br J Clin Pharmacol (2002) 1.12
Patterns of contraceptive pill taking in an inner city practice. Br Med J (Clin Res Ed) (1986) 1.10
Human antibodies to phosphocholine. IgG anti-PC antibodies express restricted numbers of V and C regions. J Immunol (1987) 1.10
Preferential idiotype-isotype associations in antibodies to dinitrophenyl antigens. J Immunol (1982) 1.08
Clostridium difficile-associated diarrhoea in hospitalised patients. J Clin Pharm Ther (2000) 1.07
Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect (2011) 1.06
Reference intervals for plasma cystatin C in healthy volunteers and renal patients, as measured by the Dade Behring BN II System, and correlation with creatinine. Clin Chem (2001) 1.06
Clinical impressions of enflurane. Br J Anaesth (1977) 1.03
Bone lead concentrations assessed by in vivo X-ray fluorescence. Clin Chem (2000) 1.02
Relation of age, race, and allotype to immunoglobulin subclass concentrations. Pediatr Res (1985) 1.02
Audit of antibiotic usage in medium-sized general hospital over an 11-year period. The impact of antibiotic policies. Pharm World Sci (1995) 0.97
Ultrastructural studies on the differentiation of spermatids in the domestic fowl. J Anat (1977) 0.96
Subnormal serum concentrations of IgG2 in children with frequent infections associated with varied patterns of immunologic dysfunction. J Pediatr (1990) 0.94
Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem (2001) 0.93
A comparison of Agiolax and lactulose in elderly patients with chronic constipation. Pharmacology (1993) 0.92
Mitogen-induced human IgG subclass expression. J Immunol (1984) 0.92
Pulmonary aspiration in mechanically ventilated patients with tracheostomies. Chest (1994) 0.90
Correlation of serum immunoglobulin subclass concentrations with antibody responses of children to immunization with Haemophilus influenzae type b polysaccharide-pertussis vaccine. J Clin Immunol (1985) 0.88
Clinical and immunologic characteristics of healthy children with subnormal serum concentrations of IgG2. Pediatr Res (1990) 0.88
Can the use of a rapid polymerase chain screening method decrease the incidence of nosocomial meticillin-resistant Staphylococcus aureus? J Hosp Infect (2008) 0.87
Faster is better--it's rarely that simple! Clin Chem (2000) 0.86
An audit of antibiotic prescribing in children with upper respiratory tract infection: the influence of auroscopic examination. Health Bull (Edinb) (1987) 0.85
Correction of positive bias of the Roche Tina-quant II hemoglobin A1c (HbA1c) assay at low HbA1c percentages. Clin Chem (2001) 0.84
Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests. Clin Chem (1997) 0.84
A unique DR-related B cell differentiation antigen. J Immunol (1983) 0.83
Audiovisual demonstration for patient counselling in the use of pressurised aerosol bronchodilator inhalers. J Clin Pharm Ther (1989) 0.82
Modulation of human airway smooth muscle proliferation by type 3 phosphodiesterase inhibition. Am J Physiol (1999) 0.82
"Bouncing" creatinine levels. N Engl J Med (1996) 0.81
Effects of azotemia on results of the boronate-agarose affinity and ion-exchange methods for glycated hemoglobin. Clin Chem (1984) 0.81
Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children. J Antimicrob Chemother (1999) 0.81
Antibody interference with the Abbott AxSym immunoassay for thyroid-stimulating hormone. Clin Chim Acta (1999) 0.81
A hospital system glucose meter that produces plasma-equivalent values from capillary, venous, and arterial blood. Clin Chem (1997) 0.81
Comparison between the CEDIA and EMIT II immunoassays for the determination of benzodiazepines. Clin Chim Acta (1998) 0.81
Mechanisms of dopamine and dobutamine interference in biochemical tests that use peroxide and peroxidase to generate chromophore. Clin Chem (1998) 0.80
A pharmacokinetic and pharmacodynamic comparison of plain and enteric-coated prednisolone tablets. Br J Clin Pharmacol (1992) 0.80
Coexpression of parathyroid hormone-related protein and its receptor in breast carcinoma: a potential autocrine effector system. Mod Pathol (1998) 0.80
Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A1C in an automated ion-exchange HPLC method. Clin Chem (1998) 0.80
A structurally aberrant immunoglobulin paraprotein in a patient with multiple myeloma and corneal crystal deposits. Am J Med (1990) 0.80
The effect of pH on the buccal and sublingual absorption of captopril. Eur J Clin Pharmacol (1995) 0.79
Estimation of blood enflurane concentrations by gas-liquid chromatography. Br J Anaesth (1977) 0.79
Expression of human IgG subclasses. Ann Clin Lab Sci (1987) 0.78
Comparing the efficacy of cisapride and ranitidine in oesophagitis: a double-blind, parallel group study in general practice. Br J Clin Pract (1994) 0.78
Point-of-care testing. Cost issues and impact on hospital operations. Clin Lab Med (2001) 0.78
Effect of mycobacterial phospholipids on interaction of Mycobacterium tuberculosis with macrophages. Infect Immun (2001) 0.78
Characterization of monoclonal antibodies against ovine prolactin: suitability for use in immunocytochemical analysis of rat prolactin. J Histochem Cytochem (1990) 0.77
Stability of FK506 (tacrolimus) in whole-blood specimens. Clin Chem (1995) 0.77
A point prevalence survey of antibiotic use in four acute-care teaching hospitals utilizing the European Surveillance of Antimicrobial Consumption (ESAC) audit tool. Epidemiol Infect (2011) 0.77
Immunologic and clinical status of blood donors with subnormal levels of IgG2. J Allergy Clin Immunol (1990) 0.76
Oxygen carriers as blood substitutes. Past, present, and future. Clin Orthop Relat Res (1998) 0.76
Two automated prolactin immunoassays evaluated with demonstration of a high-dose "hook effect" in one. Clin Chem (1992) 0.76
On the structure of the vascular body in the domestic fowl. J Anat (1978) 0.75
Interference in ionized calcium measurements by heparin salts. Clin Chem (1994) 0.75
Out of the fire and into the frying pan: thoughts in anticipation of a new contract. J R Coll Gen Pract (1989) 0.75
The assessment in man of the beta-adrenoceptor blocking activity and cardioselectivity of H-I 42 BS, a long acting beta-adrenoceptor blocking drug. Br J Clin Pharmacol (1987) 0.75
Hyponatremia. N Engl J Med (2000) 0.75
Buccal absorption of enalapril and lisinopril. Eur J Clin Pharmacol (1998) 0.75
Vascular changes in bone in calcium deficiency. East Afr Med J (1969) 0.75
Letter to the Editor: The effects of hyperlipidaemia, hyperbilirubinaemia and haemolysis on tests performed by the Olympus AU 5000 multiple analyser. J Automat Chem (1989) 0.75
Evaluation of a new colorimetric assay for serum lithium. Ther Drug Monit (1994) 0.75
A HRG-based costing model for estimating pharmacy costs associated with surgical procedures. J Clin Pharm Ther (2004) 0.75
Endogenous serum antibodies that interfere with a common thyroid hormone uptake assay: characterization and prevalence. Clin Chem (1994) 0.75
Positive interferences with the Ektachem total CO2 assay from therapy with topical cerous nitrate. Clin Chem (1990) 0.75
Mitogen-induced human IgG subclass expression. II. IgG1 and IgG3 subclasses are preferentially stimulated by a combination of Staphylococcus aureus Cowan I and pokeweed mitogen. Hum Immunol (1989) 0.75
A dental wife's viewpoint: people-to-people tour of Eastern and Western Europe. J Tenn Dent Assoc (1977) 0.75
Use of a United States-based laboratory as a hematopathology reference center for a developing country: logistics and results. Int J Lab Hematol (2012) 0.75
Sublingual captopril--a pharmacokinetic and pharmacodynamic evaluation. Eur J Clin Pharmacol (1991) 0.75
Specific measurement of cyclosporine concentrations in whole blood: radioimmunoassay and fluorescence polarization immunoassay compared. Clin Chem (1991) 0.75
New enzymatic CO2 slide on the Ektachem 700 XR analyzer eliminates interference from nitrate/nitrite ions. Clin Chem (1992) 0.75
Practical steps to deal with methicillin-resistant Staphylococcus aureus in hospitals. J Hosp Infect (2010) 0.75
Captopril versus perindopril: a double blind study in essential hypertension. J Hum Hypertens (1989) 0.75
Limited linear range of the Abbott AxSYM serum and erythrocyte folate methods. Clin Chem (1999) 0.75
An experimental study of the fate of autografts of whole-thickness skin used to replace the anterior cruciate ligament. Vet Rec (1966) 0.75
Falsely increased i-STAT chloride results for blood samples with increased urea. Clin Chem (2001) 0.75
Turbidimetric assay of IgG with use of single monoclonal antibodies. Clin Chem (1986) 0.75
Inaccurate values for direct bilirubin with some commonly used direct bilirubin procedures. Clin Chem (1985) 0.75
Problems with therapeutic monitoring of cyclosporine using silicone central venous line samples. Transplantation (1991) 0.75
Nonlinearity of calcium measurement on the Kodak Ektachem at concentrations > 110 g/L (slide generations 18 and 19) Clin Chem (1993) 0.75
Chlordiazepoxide metabolite accumulation in liver disease. Med Toxicol Adverse Drug Exp (1989) 0.75
A double-blind and cross-over comparison of once daily doxazosin and placebo with steady-state pharmacokinetics in elderly hypertensive patients. Eur J Clin Pharmacol (1988) 0.75
More on "hook effects" in immunometric assays for prostate-specific antigen. Clin Chem (1989) 0.75
Measurement of cyclosporine concentrations in whole blood: HPLC and radioimmunoassay with a specific monoclonal antibody and 3H- or 125I-labeled ligand compared. Clin Chem (1989) 0.75
Stratus automated creatine kinase-MB assay evaluated: identification and elimination of falsely increased results associated with a high-molecular-mass form of alkaline phosphatase. Clin Chem (1989) 0.75